Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Cancer cell or component thereof
Reexamination Certificate
2008-04-22
2008-04-22
Helms, Larry R. (Department: 1643)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Cancer cell or component thereof
C435S001100
Reexamination Certificate
active
07361360
ABSTRACT:
The present invention relates to a delipidation method employing a solvent system useful for extracting lipids from cancer cells, thereby creating a modified cancer cell particle. Upon delipidation of the cancer cells, a portion of the cancer cell antigens remain intact. These exposed antigens, or epitopes, foster and promote antibody production. The resulting modified cancer cell particle, or portions of the cancer cell, initiate a positive immunogenic response when administered to an animal or human and help to treat, prevent or delay the onset of cancer. The present invention provides autologous and heterologous vaccine compositions comprising the modified cancer cell with a pharmaceutically acceptable carrier. The present invention provides method of administering these vaccines to treat, prevent or delay the onset of cancer.
REFERENCES:
patent: 2004/0202676 (2004-10-01), Rybudo et al.
patent: 2005/0004004 (2005-01-01), Bellotti et al.
Bachmann, M.F., Wolint, P., Schwarz, K., and Oxenius, A. Recall proliferation potential of memory CD8+ T cells and antiviral protection. 2005. Journal of Immunology, vol. 175, pp. 4677-4685.
Efferson, C.L., Kawano, K., Tsuda, N., Palese, P., Garcia-Sastre, A., and Ioannides, C.G. Stimulation of human T cells by an influenza A vector expressing a CTL epitope from the HER-2
eu protooncogene results in higher numbers of antigen-specific TCRhi cells than stimulation with peptide. 2005. Anticancer Research, vol. 25, pp. 715-724.
Wheeler, C.M. Preventative vaccines for cervical cancer. 1997. Salud Publica de Mexico, vol. 39, No. 4.
Stedman's Medical Dictionary. On-line version, 2000. Vaccine definition.
Fields, et al., “Murine Dendritic Cells Pulsed With Whole Cell Tumor Lysates Mediate Potent Antitumor Immune Responsesin Vitroandin Vivo,” Natl. Acad. Sci USA, vol. 95, pp. 9482-9487 (1998).
Kitabwalla, et al., “Enhancement of Cell Mediated Immune Responses Using Lipid Depleted Lentivirus as Immunogen: A Novel Approach for Inducing Recognition of New Viral Epitopes,”Vaccine, vol. 23, pp.4666-4677 (2005).
Akeefe Hassibullah
Kitabwalla Moiz
Gussow Anne M.
Helms Larry R.
Kilpatrick & Stockton LLP
Lipid Sciences, Inc.
LandOfFree
Method of treating cancer cells to create a modified cancer... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating cancer cells to create a modified cancer..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating cancer cells to create a modified cancer... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2783788